Directory
>
Sophie Visonneau
Sophie Visonneau
Vice President, Head of Clinical Operations | Xencor
San Diego, California, United States
Sophie Visonneau
Summary
Sophie Visonneau is a seasoned Clinical Development Operations Leader with over 25 years of experience in the biotech and pharmaceutical industries. She has held senior leadership roles in various organizations, including as the Chief Operating Officer of a venture-funded biotech company. Her extensive expertise covers the full drug development lifecycle, from early research to clinical execution, including successful submissions for global drug approvals. Sophie is adept at managing cross-functional teams and has a proven track record of driving operational excellence across multiple therapeutic areas. She is known for her ability to mentor and lead large teams, while also being flexible enough to contribute hands-on when needed. Her educational background includes a PhD in Immunobiotechnology, underscoring her strong foundation in the sciences. Sophie is passionate about fostering innovation within clinical operations and enhancing collaboration with external stakeholders.
Sophie Visonneau
Work Experience
Vice President, Head of Clinical Operations at
Xencor
September 2023 - Present
Vice President Clinical Development at
Heron Therapeutics, Inc.
July 2022 - June 2023
Vice President Clinical Operations at
Heron Therapeutics, Inc.
May 2021 - July 2022
Vice President Clinical Operations at
Arena Pharmaceuticals, Inc.
April 2020 - April 2021
Vice President Clinical Operations at
Tocagen
March 2018 - April 2020
Chief Operating Officer at
Tioga Pharmaceuticals, Inc.
April 2014 - February 2018
Senior Director, Head Global Clinical Operations at
Shire
January 2012 - March 2014
Vice President Clinical Operations at
Polynoma
July 2011 - January 2012
Senior Director, Global Clinical Operations International at
Biogen
February 2010 - March 2011
Director/Senior Director, Global Clinical Operations Oncology Therapeutic Area at
Biogen
February 2007 - February 2010
Director, Global Labeling Regulatory Affairs at
Amgen
April 2006 - February 2007
eCTD Module 5 and 2 Leader for Global BLA Submission at
Amgen
July 2004 - February 2007
Sr. Manager/Associate Director, Global Clinical Research Management, Oncology Therapeutic Area at
Amgen
April 2002 - July 2004
Director, Oncology Therapeutic Product Development at
Immunomedics
September 2001 - April 2002
Clinical Scientist/Senior Clinical Scientist, Oncology Clinical Research North America at
GSK
September 1999 - September 2001
PostDoctoral Fellow/Staff Scientist at
The Wistar Institute
June 1992 - September 1999
Pre-Doctoral Fellow at
Hospital La Pitie Salpetriere
June 1986 - June 1991
Research Assistant at
Thomas Jefferson University
July 1986 - September 1986
Sophie Visonneau
Education
University of Sciences Pierre et Marie Curie, Paris, Phd
January 1992
University of Sciences Pierre et Marie Curie, Paris, Ms
January 1987
University of Medical Sciences Kremlin-Bicetre, Paris, Specialty Course, Experimental Oncology And Tumor Immunology
January 1986
University of Sciences Pierre et Marie Curie, Paris, Bsc.
January 1986
Frequently Asked Questions about Sophie Visonneau
What is Sophie Visonneau email address?
Sophie Visonneau's primary email address is **********@herontx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sophie Visonneau work for?
Sophie Visonneau is a Vice President, Head of Clinical Operations at Xencor, a company specializing in Commercial physical research.
Where Sophie Visonneau graduated from?
Sophie Visonneau holds a degree in Immunobiotechnology from University of Sciences Pierre et Marie Curie, Paris.
How can I directly contact Sophie Visonneau?
To contact Sophie Visonneau directly, you can use the email address **********@herontx.com. Complete contact information is available upon registration with Muraena.
Is Sophie Visonneau an immigrant?
Yes, Sophie Visonneau is an immigrant and currently based in United States
Who is Sophie Visonneau?
Sophie Visonneau is a seasoned Clinical Development Operations Leader with over 25 years of experience in the biotech and pharmaceutical industries. She has held senior leadership roles in various organizations, including as the Chief Operating Officer of a venture-funded biotech company. Her extensive expertise covers the full drug development lifecycle, from early research to clinical execution, including successful submissions for global drug approvals. Sophie is adept at managing cross-functional teams and has a proven track record of driving operational excellence across multiple therapeutic areas. She is known for her ability to mentor and lead large teams, while also being flexible enough to contribute hands-on when needed. Her educational background includes a PhD in Immunobiotechnology, underscoring her strong foundation in the sciences. Sophie is passionate about fostering innovation within clinical operations and enhancing collaboration with external stakeholders.
Sophie`s contact details
**********@herontx.com
**********@xencor.com
Colleagues
Patent Attorney (retired but consulting for Xencor)
Sr. Vice President Regulatory Affairs and Quality Assurance
Executive Director, Nonclinical and Bioanalytical Development
Vice President, Program Leadership and Strategic Alliances
Executive Director, Human Resources
Vice President, Biometrics
Vice President
Executive Director Regulatory CMC
Executive Director, CMC Operations – Drug Product and Supply Chain
VP Discovery Biology and Pharmacology